How Baseline Assessment of AMD Lesion Type Influences Clinical Decisions and Outcomes Careful diagnosis and phenotyping of neovascular AMD patients is still required in the anti-VEGF era

Great Debates in RVO Therapy An anti-VEGF and steroid gain FDA sanction, but many clinical questions remain

A Brave New World The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement